CON: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should not Undergo Liver Transplantation
Maureen Whitsett, Vivian Ortiz, Ethan M. Weinberg – 19 November 2021
CON: Liver Transplantation in the Times of COVID‐19: Patients with COVID‐19 Infection Should not Undergo Liver Transplantation
Maureen Whitsett, Vivian Ortiz, Ethan M. Weinberg – 19 November 2021
Letter to the editor: New kid in the playground: HBcrAg and risk of HCC
Jer‐Wei Wu, Tai‐Chung Tseng, Jia‐Horng Kao – 19 November 2021
Joining the Fight: Enhancing Alcohol Treatment Education in Hepatology
Adam C. Winters, Elizabeth S. Aby, Oren K. Fix, Margarita German, Lamia Y.K. Haque, Gene Y. Im – 19 November 2021
Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma
Nikita Sandeep Wagle, Sulki Park, David Washburn, Robert L. Ohsfeldt, Nicole E. Rich, Amit G. Singal, Hye‐Chung Kum – 18 November 2021 – Hepatocellular carcinoma (HCC) disproportionately affects racial, ethnic, and low socioeconomic status (SES) populations. However, the interaction between race, ethnicity, and neighborhood SES in HCC prognosis is not well explored. This study evaluates the interaction between race and ethnicity and neighborhood SES on curative treatment utilization and overall survival among patients with HCC in the United States.
Reply
Panagiota Palla, Chrysovalantis Vergadis, Stratigoula Sakellariou, Theodoros Androutsakos – 18 November 2021